Tabunda, Baby Girl .

HRN: 23-17-21  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2023
AMPICILLIN 250MG (VIAL)
06/12/2023
06/18/2023
IV
80
Q12
Sepsis Neonatarum
Waiting Final Action 
06/12/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
06/12/2023
06/18/2023
IV
8
Q24
Sepsis Neonatarum
Waiting Final Action 
06/14/2023
CEFOTAXIME 500MG (VIAL)
06/14/2023
06/20/2023
IV
80mg
Q12
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: